Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin.
about
Redox-Mediated Suberoylanilide Hydroxamic Acid Sensitivity in Breast Cancer.Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast CancerOpportunities and challenges of radiotherapy for treating cancer.Identification and Characterization of Cadmium-Related Genes in Liver Carcinoma.Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells.Neurodegeneration and the Brain Tumor Microenvironment. [corrected]A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo.
P2860
Q35822102-F36C2045-AF4F-423F-BD90-EFB88715D623Q35898006-9570D756-CF81-4D03-802E-D816F5CB87B6Q38539957-ED121DE9-8308-42A9-8D9C-DDE5A751F87DQ38645044-9B22E407-1626-43E2-9713-E3CFB3FC933BQ38837835-AB0548EC-C19B-4722-9CB2-D0BE387A1055Q40494622-5B57C88B-73F4-41D9-A8C5-22404478F858Q55264209-5D15BA17-E228-4A94-983D-33206241597A
P2860
Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Suppression of the xCT-CD44v a ...... t cancer cells to doxorubicin.
@en
Suppression of the xCT-CD44v a ...... t cancer cells to doxorubicin.
@nl
type
label
Suppression of the xCT-CD44v a ...... t cancer cells to doxorubicin.
@en
Suppression of the xCT-CD44v a ...... t cancer cells to doxorubicin.
@nl
prefLabel
Suppression of the xCT-CD44v a ...... t cancer cells to doxorubicin.
@en
Suppression of the xCT-CD44v a ...... t cancer cells to doxorubicin.
@nl
P2860
P1476
Suppression of the xCT-CD44v a ...... t cancer cells to doxorubicin.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10549-014-3068-6
P407
P577
2014-08-02T00:00:00Z